Status:
RECRUITING
Exercise Therapy After Caudal Epidural Steroid Injection
Lead Sponsor:
Çankırı Karatekin University
Conditions:
Intervertebral Disc Displacement
Low Back Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
\*\*Brief Summary\*\* Lumbar radicular pain arising from intervertebral disc herniation is commonly managed with a caudal epidural steroid injection (CESI), a minimally invasive procedure that delive...
Detailed Description
Scientific Rationale and Background Caudal epidural steroid injection (CESI) is widely employed to attenuate lumbosacral radicular pain by delivering glucocorticoids into the sacral hiatus, thereby di...
Eligibility Criteria
Inclusion
- Age 18 to 70 years.
- MRI-confirmed lumbar intervertebral disc herniation.
- Has received a caudal epidural steroid injection (CESI) within the past 2 weeks at Çankırı State Hospital.
- Low-back or leg pain intensity ≥ 3 cm on a 10-cm Visual Analogue Scale after the injection.
- Medically cleared for moderate aerobic and core-stabilisation exercise (no cardiac or orthopaedic contraindications).
- Able to attend supervised physiotherapy three times per week for six weeks.
- Willing and able to give written informed consent and to comply with study procedures.
- Sufficient Turkish literacy (minimum primary-school education) to complete questionnaires.
Exclusion
- Uncontrolled systemic disease (e.g., poorly controlled diabetes mellitus, congestive heart failure, active hepatitis C or other significant liver disease).
- Neurological red flags such as myelopathy or cauda equina syndrome.
- Previous lumbar spine surgery at the affected disc level.
- Current pregnancy or planning pregnancy during the study period.
- Severe musculoskeletal, cardiovascular, or respiratory condition that precludes safe exercise participation.
- Use of systemic corticosteroids or opioid analgesics that cannot be stabilised for the duration of the trial.
- Ongoing litigation or workers' compensation claim related to low-back pain.
- Inability to communicate effectively with study staff or to follow instructions.
Key Trial Info
Start Date :
April 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06956664
Start Date
April 28 2025
End Date
February 15 2026
Last Update
August 8 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Çankırı Karatekin University
Çankırı, Turkey (Türkiye)
2
Çankırı State Hospital
Çankırı, Turkey (Türkiye)
3
Çankırı State Hospital
Çankırı, Turkey (Türkiye)